Exclusive cyclin A2 or cyclin complex-targeting molecules are important in inhibiting the cell cycle and thus cancer cell proliferation, therefore these inhibitors might be useful for the treatment of AR-V7-expressing CRPC. The gene discussed is CCNA2; the disease is cancer.